AI assistant
Sending…
Jazz Pharmaceuticals plc — Director's Dealing 2010
Aug 17, 2010
30751_dirs_2010-08-17_74b24ff3-3353-4fab-bb26-cc44d0f4acf4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2009-08-13
Reporting Person: Colligan Joan (Principal Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-08-13 | Common Stock | J | 250 | — | Acquired | 11477 | Direct |
| 2009-08-13 | Common Stock | S | 93 | $6.97 | Disposed | 11384 | Direct |
| 2010-08-13 | Common Stock | J | 250 | — | Acquired | 11634 | Direct |
Footnotes
F1: Settlement of Restricted Stock Units
More from Jazz Pharmaceuticals plc
Regulatory Filings
2026
May 29
Annual Report
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2